MARIACELIS CAPELING: Open Payments
NPI 1083078901 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 14 payments from 6 companies in 2025. Trend: 2023 $273 · 2024 $314 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Lilly USA, LLC | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
Products named: Wegovy, FARXIGA, JARDIANCE, MOUNJARO, PREVNAR 20, The Cologuard Plus Collection Kit, BREZTRI, Ozempic.
Industry payments across CA — which companies pay providers there.
